ENTITY
CSL Ltd

CSL Ltd (CSL AU)

120
Analysis
Health CareAustralia
CSL Limited develops, manufactures and markets human pharmaceutical and diagnostic products derived from human plasma. The Company's products include pediatric and adult vaccines, infection, pain medicine, skin disorder remedies, antivenoms, anticoagulants, and immunoglobulins.
more
bullishTencent
29 May 2020 14:48

COVID-19 and ESG: Tencent, Alibaba Lead in Coronavirus Aid for Asia Pacific Region

"Social" has been a third-wheel ESG pillar for a long time. Not that it matters any less, and there is plenty of evidence that strong Social-pillar...

Logo
633 Views
Share
bearishMSCI ACWI Index
27 Mar 2020 09:25

Global Equity Strategy: Initial Low Established

Several equity indexes and indicators we watch are telling us an initial primary low has been established for global equities (ACWI-US). At the...

Logo
453 Views
Share
19 Oct 2019 10:51

Aussie Equities Model Portfolio Update (October): Sticking to the Knitting

Our model portfolio has added 200bp of Alpha since our last update and our stock selection remains broadly unchanged.  However, we make some key...

Logo
359 Views
Share
30 Sep 2019 07:47

Developed Markets Opportunities

Continue to favor EAFE over EM. As long as the U.S. dollar remains elevated, we believe  developed international (EAFE) will remain in a leadership...

Logo
462 Views
Share
20 Sep 2019 11:25

The Deadcat Bounce in Aussie Value

The Global rotation away from Defensive stocks to cyclical Growth and Value over the past few weeks has not been impressive enough to convince us...

Logo
468 Views
Share
x